News — author-amatullah RSS



Acorn’s Commitment to Quality – A 10 Point Process

When it comes to freezing the clock on your cells, quality matters. At Acorn Biolabs we strive for operational excellence. The way we collect, analyze, and store human hair follicles is done with strict adherence to Current Good Manufacturing and Tissue Practices (cGMP/cGTP). For most, cGMP/cGTP compliance is not a phrase that comes to mind. For those that deal with it daily, it is synonymous with a never-ending mountain of paperwork. So why is it such an important part of Acorn’s cell preservation service For any respectable biotechnology or pharmaceutical company, this phrase is at the core of every practice. Poor quality products are not only a health hazard but a waste of money for governments, companies, and individual consumers...

Continue reading



Stem cell therapy: Conditions currently approved in Canada

As of 2021, Canada has approved a total of 3 cellular therapeutic products for use on patients. These include the use of stem cells for the treatment of acute lymphoblastic leukemia (ALL), Adult B-cell Lymphoma, and Graft V Host disease. Most approved therapies use hematopoietic stem cells (HSC), found in bone marrow, blood, and the umbilical cord all contain HSCs. The future of stem cell treatments is dependent on Induced Pluripotent Stem Cell (IPSC) technology. IPSC technology involves reprogramming skin or blood cells into a pluripotent state .

Continue reading